tert-Butyl 7-oxo-8-phenyl-2,6-diazaspiro[3.4]octane-2-carboxylate

Catalog No. :
ACTACV054
CAS No. :
1330765-75-7
Molecular Formula :
C17H22N2O3
Molecular Weight :
302.37

IUPAC Name:tert-butyl 7-oxo-8-phenyl-2,6-diazaspiro[3.4]octane-2-carboxylate

tert-Butyl 7-oxo-8-phenyl-2,6-diazaspiro[3.4]octane-2-carboxylate structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
250mg97%$670.00Login to see priceInquiryInquiry
1g97%$1675.00Login to see priceInquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Nametert-Butyl 7-oxo-8-phenyl-2,6-diazaspiro[3.4]octane-2-carboxylate
IUPAC Nametert-butyl 7-oxo-8-phenyl-2,6-diazaspiro[3.4]octane-2-carboxylate
MDL No.MFCD20230716
Molecular FormulaC17H22N2O3
Molecular Weight302.37
SMILESO=C(N1CC2(CNC(C2C3=CC=CC=C3)=O)C1)OC(C)(C)C
InChI KeyHUBUYYQIARIBBA-UHFFFAOYSA-N
SynonymTert-Butyl 7-Oxo-8-Phenyl-2,6-Diazaspiro[3.4]Octane-2-Carboxylate(WX105896);Tert-Butyl 7-Oxo-8-Phenyl-2,6-Diazaspiro[3.4]Octane-2-Carboxylate;tert-butyl 6-oxo-5-phenyl-2,7-diazaspiro[3.4]octane-2-carboxylate;2,6-Diazaspiro[3.4]octane-2-carboxylic acid, 7-oxo-8-phenyl-, 1,1-dimethylethyl ester
CAS No.1330765-75-7

Safety Data

Pictogram
Harmful or irritant
Signal Word
Achtung
Hazard Statement(s)
H302-H315-H319-H335
Precautionary Statement(s)
P261-P280-P301+P312-P302+P352-P305+P351+P338

Synthetic Route by SureRoute

1. ACTACV054 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACTACV054 route product structure diagram
    ACTACV0541330765-75-7
Inquiry

2. ACTACV054 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACTACV054 route product structure diagram
    ACTACV0541330765-75-7
Inquiry

Comments (0)